0.68 - 0.75
0.33 - 0.86
12.91M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.56%
Positive revenue growth while 0425.HK is negative. John Neff might see a notable competitive edge here.
9.40%
Positive gross profit growth while 0425.HK is negative. John Neff would see a clear operational edge over the competitor.
21.32%
EBIT growth above 1.5x 0425.HK's 1.33%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
21.32%
Operating income growth above 1.5x 0425.HK's 1.33%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
66.19%
Net income growth above 1.5x 0425.HK's 12.03%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
67.59%
EPS growth above 1.5x 0425.HK's 12.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
67.59%
Diluted EPS growth above 1.5x 0425.HK's 12.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.74%
Share reduction while 0425.HK is at 0.63%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.67%
Reduced diluted shares while 0425.HK is at 0.65%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-166.08%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-816.18%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
47933.84%
10Y revenue/share CAGR above 1.5x 0425.HK's 463.80%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
1.19%
5Y revenue/share CAGR under 50% of 0425.HK's 81.59%. Michael Burry would suspect a significant competitive gap or product weakness.
9.55%
3Y revenue/share CAGR under 50% of 0425.HK's 54.30%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-4802.15%
Negative 10Y OCF/share CAGR while 0425.HK stands at 41.71%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-181.71%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-137.36%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
387.58%
Net income/share CAGR above 1.5x 0425.HK's 250.10% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-73.88%
Negative 5Y net income/share CAGR while 0425.HK is 38.52%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-43.89%
Negative 3Y CAGR while 0425.HK is 35.11%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
152.38%
5Y equity/share CAGR above 1.5x 0425.HK's 59.52%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
54.75%
3Y equity/share CAGR above 1.5x 0425.HK's 31.83%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-87.59%
Negative 5Y dividend/share CAGR while 0425.HK stands at 313.93%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
141.46%
3Y dividend/share CAGR at 50-75% of 0425.HK's 268.52%. Martin Whitman might see a weaker short-term approach to distributing cash.
24.83%
AR growth well above 0425.HK's 1.38%. Michael Burry fears inflated revenue or higher default risk in the near future.
-12.51%
Inventory is declining while 0425.HK stands at 7.94%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
21.68%
Asset growth above 1.5x 0425.HK's 3.13%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.64%
75-90% of 0425.HK's 1.99%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
281.70%
Debt growth far above 0425.HK's 8.78%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
75.26%
We increase R&D while 0425.HK cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
7.69%
We expand SG&A while 0425.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.